Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-20-006549

EVP, Research & Development gave up 538 shares (to pay taxes)

  • EVP, Research & Development acquired 1,213 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sandrock Alfred EVP, Research & Development 2020-02-15 Option exercise +1,213 15,019.25 D
Sandrock Alfred EVP, Research & Development 2020-02-15 Shares withheld for taxes −538 $333.00 $179,154 14,481.25 D
Derivatives
Sandrock Alfred EVP, Research & Development 2020-02-15 Option exercise · Restricted Stock Unit −1,213 915 D
Sandrock Alfred EVP, Research & Development 2020-02-15 Other disposition · Restricted Stock Unit −915 0 D
Loading xslF345X03/form4.xml…